Janssen to Acquire Investigational Bermekimab from XBiotech
Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson, announced that it has entered a definitive agreement to acquire all rights to the investigational…
Read More...
Read More...
